Percutaneous coronary intervention (PCI) is a catheter-based procedure to restore blood flow in coronary arteries blocked by atherosclerotic plaque. A cardiologist inserts a thin tube (catheter) through a small puncture in the wrist or groin, navigates it to the blocked artery under X-ray guidance, and uses a balloon and usually a stent to open the blockage — without opening the chest.
Why Coronary Arteries Block
The coronary arteries supply oxygenated blood to the heart muscle itself. Atherosclerosis — the gradual buildup of fatty deposits (plaques) in the arterial wall — can narrow these arteries over time. When blood flow is substantially reduced, the heart muscle receives insufficient oxygen, producing chest pain (angina) during exertion. When a plaque ruptures and triggers a blood clot, blood flow can be abruptly cut off, causing a myocardial infarction (heart attack).
Restoring blood flow quickly in acute myocardial infarction reduces the amount of heart muscle that dies. PCI is the preferred reperfusion strategy for ST-elevation myocardial infarction (STEMI) when a facility capable of performing it promptly is available, according to ACC/AHA guidelines.
Access Routes
PCI is performed through one of two primary access routes:
Radial access (wrist): The catheter is inserted through the radial artery at the wrist. Radial access has become preferred at many centers because it is associated with lower rates of bleeding complications and allows patients to ambulate sooner after the procedure. Post-procedure, a compression band is applied to the wrist for a few hours.
Femoral access (groin): The catheter is inserted through the femoral artery in the upper thigh. Femoral access provides a larger artery and more stable catheter support, which can be advantageous for complex procedures. Post-procedure, the patient must remain flat for several hours to allow the puncture site to seal.
The Procedure Step by Step
Preparation and access: The access site is cleaned and a local anesthetic injected. A small needle punctures the artery, and a short plastic sheath is inserted to protect the access site and provide a stable entry point for catheters.
Coronary angiography: A diagnostic catheter is advanced to the ostium (opening) of the coronary arteries. Contrast dye is injected and X-ray images (angiograms) are captured, revealing the location and severity of blockages. This step defines the anatomy before treatment.
Guide catheter placement: A guide catheter — a stiffer, larger catheter — is positioned at the coronary ostium to provide support for the intervention.
Guidewire crossing: A thin guidewire (typically 0.014 inches in diameter) is advanced through the guide catheter, across the blockage, and into the vessel beyond. This wire serves as a rail over which balloons and stents are delivered. Crossing complex or total occlusions can be technically demanding.
Balloon angioplasty: A balloon catheter is advanced over the guidewire to the blockage. The balloon is inflated to high pressure for several seconds, compressing the plaque against the vessel wall and opening the lumen.
Stent deployment: In most PCIs, a stent — a metal mesh tube — is deployed at the site of the blockage. Modern drug-eluting stents (DES) are coated with medications that prevent scar tissue from re-narrowing the artery (restenosis) in the months after the procedure. The stent is mounted on a balloon and deployed by inflating the balloon, expanding the stent into the vessel wall where it remains permanently.
Post-deployment assessment: The result is assessed by repeat angiography and sometimes by intravascular imaging (intravascular ultrasound or optical coherence tomography) to confirm the stent is fully expanded and apposed to the vessel wall.
Closure: The access sheath is removed and the access site is compressed or sealed with a closure device.
Role of Robotics in PCI
Robotic PCI systems allow the cardiologist to manipulate guidewires, balloons, and stents from a radiation-shielded workstation rather than standing at the patient bedside. This reduces occupational radiation exposure for the interventionalist, who otherwise stands at the bedside during prolonged fluoroscopic procedures wearing heavy lead protective garments.
The robotic system translates the cardiologist’s hand movements at the console into precise guidewire and catheter movements at the patient. The cardiologist retains full control — robotic PCI systems are master-slave controlled, not autonomous.
Cathbot develops robotic systems for cardiovascular catheter procedures, with its R-One platform designed for robotic PCI. WeMed Medical developed the ETcath robotic catheter system, which received NMPA approval in March 2025 as the first fully domestically developed coronary interventional robot in China.
Indications for PCI vs. Bypass Surgery
PCI and coronary artery bypass grafting (CABG) are both revascularization strategies. The choice depends on anatomy (number of vessels affected, lesion complexity), function (left ventricular function, presence of diabetes), and clinical context (acute vs. stable).
For simple one- or two-vessel disease with straightforward anatomy, PCI is generally preferred for its lower procedural invasiveness. For complex three-vessel disease or left main coronary artery involvement, bypass surgery may offer better long-term outcomes, per published guidelines — the choice is made through a multidisciplinary heart team discussion.
Frequently Asked Questions
Is PCI the same as angioplasty?
The terms are often used interchangeably, but technically, angioplasty refers specifically to balloon dilation of the blocked artery, while PCI encompasses angioplasty plus stent placement and other adjunctive tools. In contemporary practice, PCI almost always includes a stent.
How long does a PCI procedure take?
For uncomplicated PCI (single vessel, straightforward lesion), the procedure commonly takes 30–60 minutes including the angiography phase. Complex PCIs — total occlusions, bifurcation lesions, multiple vessels — can take several hours.
What is a drug-eluting stent?
A drug-eluting stent (DES) is a metal mesh stent coated with a polymer that releases a medication (typically an antiproliferative drug such as sirolimus or everolimus) over several months. The drug inhibits smooth muscle cell proliferation, reducing the risk that scar tissue will grow into the stent and re-narrow the artery.
What medications are required after PCI with a stent?
Patients who receive a coronary stent are prescribed dual antiplatelet therapy — typically aspirin plus a P2Y12 inhibitor — for a period ranging from one month to twelve months or longer, depending on stent type, clinical indication, and bleeding risk. This medication prevents clot formation on the stent surface while the vessel wall heals around it.
What makes PCI technically complex?
Lesion complexity factors include calcification (hardened plaque requiring special tools to crack or treat), bifurcation lesions (where the blockage occurs at an artery branch), chronic total occlusions (arteries completely blocked for a prolonged period), and left main disease (involvement of the main trunk supplying most of the left heart). These scenarios require advanced techniques and equipment beyond standard balloon and stent delivery.